Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triflusal for Insulin Resistance in Obesity
NCT00162799Phase 2Completed
- Sponsor
- Uriach
- Start
- Jul 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Triflusal in insulin resistance (IR), sponsored by Uriach. Started Jul 2002; status: completed.
02
Drugs
Triflusal
03
Conditions
insulin resistance (IR)
Beyond the preview
Go deeper on NCT00162799.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00162799.